Standard BioTools Inc. Common Stock
LABStandard BioTools Inc. (LAB) is a provider of laboratory instruments, software, and consumables used in life science research and diagnostics. The company specializes in enabling scientific and clinical discoveries through its innovative solutions for genomics, proteomics, and cell analysis, supporting pharmaceutical, biotech, and academic research communities.
Company News
Standard BioTools will report its second quarter 2025 financial results on August 11, 2025, hosting a conference call at 4:30 p.m. ET to discuss financial performance and operational progress.
Standard BioTools Inc. (NASDAQ: LAB) announced that it will report its first quarter 2025 financial results on May 6, 2025, and host a conference call to discuss the results and operational progress.
Standard BioTools Inc. (NASDAQ: LAB) announced preliminary and unaudited revenue results for the fourth quarter and full year 2024, with expected revenue of approximately $46.5 million for Q4 2024 and $174 million for the full year 2024. The company's CEO discussed progress in reducing operating expenses and plans to leverage the company's founda...
Standard BioTools Inc. (NASDAQ: LAB) announced that its President and CEO, Michael Egholm, PhD, will present at the upcoming 43rd Annual J.P. Morgan Healthcare Conference on January 16th, 2024.
Standard BioTools Inc. announced the appointment of Alex Kim as its new Chief Financial Officer, effective November 11, 2024. Kim, a co-founder and former Chief Operating Officer, brings extensive financial and operational experience in the healthcare and life sciences industries.
